The Division of Hematology/Oncology/Bone Marrow Transplantation at Children’s Mercy Kansas City is recruiting for a full-time board certified / board eligible Pediatric Hematology/Oncology physician at the Assistant or Associate Professor level with strong clinical skills who will join the Section of Oncology. The candidate for this academic clinical position should have an interest in developing a clinical or laboratory research focus with a desire to advance the field through research and collaboration. The candidate will participate in clinical, research, and educational efforts and should have an interest in mentoring residents and/or H/O fellows. The Division is made up of 29 total physicians who focus in one of 4 areas – Oncology, Hematology, Bone Marrow Transplantation, or Inpatient Hem/Onc Hospitalist care. Within the section of Oncology there are 12 physicians with varying levels of clinical, research, and programmatic leadership responsibility. Clinically, each Oncologist is teamed with an Advanced Nurse Practitioner and a Social Worker in the oversight of their primary patients. Children’s Mercy sees 170-180 newly diagnosed children annually between the ages of 0 and 21 years of age and, now teaming with the University of Kansas Cancer Center as a Consortium member institution in its NCI Cancer Center designation. Outpatient clinic facilities include 14 infusion bays and 18 exam rooms wholly dedicated to Hem/Onc. The inpatient unit has fully hepafiltered 38 private patient rooms and floor where all Hem/Onc patients are admitted. Inpatients are overseen by 4 Hem/Onc services – an inpatient resident/fellow H/O service, 1 chemo service, 1 BMT service, and 1 inpatient coagulation consultation service – all staffed by residents and/or advanced practice professionals. All medical, pathology, radiologic and surgical subspecialties are represented in CM who work closely in the care of children with cancer.
The Children’s Mercy Cancer Center is composed of physicians and scientists from multiple medical and surgical specialties and together make up various patient-specific (Survivors, Hispanic, AYA, etc), therapy-specific (Phase I, BMT, etc), and tumor-specific (Hematologic, CNS, Solid tumor/Sarcoma, etc) programs. Each program is led by a Program Director who works with their multi-specialty, multi-discipline teams to establish strong clinical, research, and education focused goal-driven efforts. Clinical and laboratory research programs are available both at CMKC and the KUCC campuses as well as our 3rd Consortium partner institution – Stowers Medical Research Institute – a basic science research institution. The Children’s Mercy Research Institute has started construction on a new 9 story research building that will include wet and dry labs including a GMP facility and vivarium. Further support of cancer research at Children’s Mercy includes our Cancer Genomics program, our Tumor Biorepository, and the Children’s Mercy Division of Clinical Pharmacology with active research in cancer pharmacogenomics. Research is actively supported by a variety of sources including NIH, Foundations, Philanthropic, and Institutional grant mechanisms strongly enhanced by our Research Administration.